← All trials
NCT05369000
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 27, 2022
- Primary completion
- Sep 30, 2023
- Completion date
- Mar 31, 2024
- First posted
- May 11, 2022
- Last posted
- Nov 21, 2022
- Enrollment
- 66
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Lava TherapeuticsLead sponsor
- Lava TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.